IndraLab

Statements


BTK inhibitors inhibits CYLD. 2 / 2
| 2

reach
"BTK inhibitors induced CYLD dependent apoptosis in non-GCB-DLBCL cell lines."

reach
"In addition, we found that knocking down CYLD in rituximab resistant non-GCB-DLBCL cells would attenuate this BTK inhibitors induced apoptosis, consequently, further confirmed that this BTK inhibitors induced CYLD dependent apoptosis in rituximab resistant non-GCB-DLBCL."